Verve Therapeutics
NEWS
When Sekar Kathiresan’s brother unexpectedly died from a heart attack, he changed the course of his life to found a company with a novel medicine that may prevent them.
The year kicked off with a bang as multiple companies raced to a public listing.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Life sciences advances continue to be an exciting opportunity for investors. Here’s a glance at the companies attracting fresh funding the past week.
Biotech companies are dominating Nasdaq’s IPO scheduled this week. Here’s who is making their big public debut.
A brief rundown of the biopharmas that brought in the cash the past week.
Sizable venture rounds from cardiac gene-editing company Verve Therapeutics and the retooled fusion protein maker Vera Therapeutics will push their lead therapies into and through the clinic over the next two years.
BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of up-and-coming life science companies in North America that launched no earlier than mid-2018.
JOBS
IN THE PRESS